RNSH

Harvett, thanks for again noting that the RNSH prostate trial has not started, five months after it was first listed by RNSH on clinicaltrials.gov

You might like to know that:
  1.  The trial is sponsored by RNSH
  2.  Noxopharm has NO control over the timing of the trial
  3.  Noxopharm intends to conduct a parallel study under THEIR control

NOX66-002A

	Column 1	Column 2
0	Status:	Under development
1	Patients:Â	Metastatic castrate-resistant prostate cancer eligible to receive palliative radiotherapy
2	Countries:Â	Australia, New Zealand
3	General description:	Company Sponsored Trial to parallel Investigator Initiated Trial NOX66-002.